Clinical trial
Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy
NCT00295555 · Yokohama City University Medical Center, Other · Completed
Key facts
| NCT number | NCT00295555 |
|---|---|
| Title | Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy |
| Official title | Effects of Doxazosin on Ambulatory Blood Pressure and Sympathetic Nervous Activity in Hypertensive Patients With Diabetic Nephropathy |
| Lead sponsor | Yokohama City University Medical Center, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Essential Hypertension, Renal Failure |
| Intervention type | Drug |
| Interventions | Effects of doxazosin on morning surge in diabetic patients |
| Enrollment | 98 |
| Start date | Jan 1, 2004 |
| Completion | Apr 1, 2007 |
| First posted | Feb 23, 2006 |
| Last update posted | May 10, 2007 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: